MENU
+Compare
MDNAF
Stock ticker: OTC
AS OF
Sep 16 closing price
Price
$0.75
Change
-$0.02 (-2.60%)
Capitalization
63.2M

MDNAF Medicenna Therapeutics Corp. Forecast, Technical & Fundamental Analysis

Medicenna Therapeutics Corp is a Canada-based immuno-oncology company... Show more

MDNAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MDNAF with price predictions
Sep 16, 2025

Aroon Indicator for MDNAF shows an upward move is likely

MDNAF's Aroon Indicator triggered a bullish signal on August 20, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 109 similar instances where the Aroon Indicator showed a similar pattern. In of the 109 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 67 cases where MDNAF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MDNAF advanced for three days, in of 226 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MDNAF moved out of overbought territory on August 12, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on September 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MDNAF as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MDNAF turned negative on August 29, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDNAF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.914) is normal, around the industry mean (20.607). P/E Ratio (0.000) is within average values for comparable stocks, (53.283). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.160). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (333.412).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MDNAF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDNAF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MDNAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MDNAF is expected to report earnings to rise 16.59% to -5 cents per share on November 14

Medicenna Therapeutics Corp. MDNAF Stock Earnings Reports
Q3'25
Est.
$-0.05
Q2'25
Est.
$-0.04
Q1'25
Beat
by $0.06
Q4'24
Est.
$-0.05
Q3'24
Beat
by $0.01
The last earnings report on July 31 showed earnings per share of -4 cents, meeting the estimate of -4 cents. With 24.68K shares outstanding, the current market capitalization sits at 63.20M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2 Bloor Street W.
Phone
+1 416 648-5555
Employees
16
Web
https://www.medicenna.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RYSKF0.350.01
+2.94%
Reysas Tasimacilik Ve Lojistik
CANN0.04N/A
+1.49%
TREES Corporation
KELRF8.03N/A
N/A
Keisei Electric Rail
MGDDF37.75N/A
N/A
CIE GENERALE DES ETABLISSEMENTS MICHELIN SA CLERMONT-FERRAND
RDBBF0.19-0.01
-5.83%
ARTICORE GROUP LTD.

MDNAF and Stocks

Correlation & Price change

A.I.dvisor tells us that MDNAF and LRMR have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDNAF and LRMR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDNAF
1D Price
Change %
MDNAF100%
-2.60%
LRMR - MDNAF
25%
Poorly correlated
+1.01%
VIR - MDNAF
25%
Poorly correlated
+1.46%
STOK - MDNAF
23%
Poorly correlated
-1.03%
CGEM - MDNAF
23%
Poorly correlated
-0.94%
PTCT - MDNAF
22%
Poorly correlated
+1.20%
More